![]() Received 4 December 2002 | Accepted 7 February 2003 | Published 18 February 2003 |
Download Reprint |
![]() |
Evaluation of the ELOVL4 gene in patients with autosomal recessive retinitis pigmentosa and Leber congenital amaurosis
Carlo Rivolta,1
Radha Ayyagari,2
Paul A. Sieving,2,3 Eliot L.
Berson,1 Thaddeus P.
Dryja1
1Ocular Molecular Genetics Institute and the Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA; 2Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI; 3National Eye Institute, NIH, Bethesda, MD
Correspondence to: Thaddeus P. Dryja, Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA, 02114, USA; Phone: (617) 573-3319; FAX: (617) 573-3168; email: thaddeus_dryja@meei.harvard.edu
Abstract
Purpose: To determine whether pathogenic mutations exist in the ELOVL4 gene in patients with inherited retinal degenerations other than Stargardt-like macular dystrophy or other hereditary macular degenerations.
Methods: All six exons comprising the open reading frame of the ELOVL4 gene were evaluated by single-strand conformation analysis, direct nucleotide sequencing, or both methods.
Results: No pathogenic mutations were found among 84 patients with autosomal recessive retinitis pigmentosa or among 51 patients with Leber congenital amaurosis (congenital retinal blindness).
Conclusions: These data support the conclusion that recessive retinitis pigmentosa and Leber congenital amaurosis are rarely if ever associated with changes in the ELOVL4 gene.
Introduction
Inherited retinopathies are a group of retinal diseases that are clinically and genetically very heterogeneous. Most are characterized by the progressive degeneration of rod and cone photoreceptors, a phenomenon that ultimately leads to severe visual impairment and blindness. For the most common form of retinal dystrophy, retinitis pigmentosa (RP), rod loss exceeds cone loss in the early stages, and there is a progressive constriction of the visual field from the periphery [1]. Conversely, in cone-rod dystrophy, cone loss far exceeds rod loss, leading to impaired color vision and progressive deterioration of central visual acuity, followed by an eventual loss of peripheral visual field as well [2]. In hereditary macular degenerations, cone and rod photoreceptors are lost in the macula, resulting in loss of central visual field and visual acuity [3]. Another example of an inherited retinopathy is Leber congenital amaurosis (LCA), in which the loss of both rods and cones is particularly severe across the entire retina, leading to blindness or markedly reduced vision within the first few months of life [4].
Different forms of retinal degeneration are typically caused by mutations in different genes. However, there are some genes (e.g., CRX [5], RPE65 [6], CRB1 [7-9], USH2A [10,11], etc.) for which different mutations result in different phenotypes.
Mutations in ELOVL4, a gene possibly involved in the elongation of very long chain fatty acids, have been recently associated with various forms of dominant macular dystrophy, including autosomal dominant Stargardt disease-3 (STGD3, OMIM 600110), autosomal dominant macular dystrophy linked to chromosome 6 (adMD; OMIM 600110) [12,13], and a form of macular dystrophy with a wide range of clinical expression [14]. So far, only two mutations have been identified, both of which are frameshifts in the terminal exon [12-14]. Both alleles cause a premature termination of the reading frame and, since they occur within the last exon, likely lead to the production of a truncated protein having a dominant-negative effect, rather than leading to an unstable, and thus untranslated, mRNA [15].
Because of the extremely narrow range of mutations so far detected and in particular the absence of null alleles, we investigated the ELOVL4 open reading frame and splice donor and acceptor sites for the presence of other mutations in patients affected with LCA and autosomal recessive RP in search of a possible correlation between different mutations and retinal phenotypes other than macular degeneration.
Methods
This study involved human subjects and conformed to the Declaration of Helsinki. Leukocyte DNA was extracted from peripheral blood of 84 unrelated patients with autosomal recessive retinitis pigmentosa and 51 unrelated patients with Leber congenital amaurosis. Patients with autosomal recessive RP (arRP) included in this study were from families with multiple affected siblings and no previous generations had RP or LCA by history or were the offspring of a consanguineous mating. Patients with LCA came from families exhibiting a recessive inheritance pattern. All six exons of the ELOVL4 gene and the immediate intronic sequences were amplified by the polymerase chain reaction (PCR) and evaluated by single strand conformation analysis, direct nucleotide sequencing, or both, by using either the primers reported in Table 1 or those previously reported [12].
Results
The mutation analysis revealed the presence of the missense change Met299Val (ATG to GTG) in 16 patients with recessive RP (15 heterozygotes and 1 homozygote) and 12 patients with LCA (all heterozygotes). One patient with recessive RP carried heterozygously the missense change Ile267Thr (ATT to ACT), and one patient with LCA was found to carry the intron change IVS3 -18 C to T. All of these changes were previously reported and are interpreted as benign polymorphisms [16], since their allelic frequency does not differ significantly between patients and unaffected controls (Table 2).
Discussion
ELOVL4 lies in a region of chromosome 6 that contains at least two other loci that have been associated with retinal degeneration: RP25 (recessive RP) [17,18], and LCA5 (recessive Leber congenital amaurosis) [19]. In a recent report, ELOVL4 was ruled out as the RP25 locus [20]. In the present paper, we could not provide any evidence that ELOVL4 is responsible for any of the inherited retinal conditions present in our set of patients. Our results make it unlikely that ELOVL4 corresponds to the actual LCA5 locus or that it accounts for large proportions of cases of arRP or LCA. To be precise, we used the binomial distribution to calculate the likelihood of our results (finding no cases with ELOVL4 mutations) if ELOVL4 caused a small percentage of arRP or LCA. Assuming that the frequency of ELOVL4 cases is f, then the chance of finding no ELOVL4 cases among a set of N patients is (1-f)N. Based on the numbers of patients screened, we would have had more than a 95% chance of finding at least one ELOVL4 case if ELOVL4 caused 4% or more of arRP or 6% or more of LCA.
Acknowledgements
This work was supported by grants from the Foundation Fighting Blindness, the National Eye Institute (EY00169, EY08683, EY13198), and Research to Prevent Blindness Inc.
References
1. Berson EL. Retinitis pigmentosa. The Friedenwald Lecture. Invest
Ophthalmol Vis Sci 1993; 34:1659-76.
2. Berson EL, Gouras P, Gunkel RD. Progressive cone-rod degeneration.
Arch Ophthalmol 1968; 80:68-76.
3. Franceschetti A, Francois J, Babel J. Les Heredodegenerescences Chorio-retiniennes. Paris: Masson & Cie; 1963.
4. Leber T. Uber retinitis pigmentosa und angeborene amaurose. Archiv für Ophthalmologie 1869; 15:1-25.
5. Sohocki MM, Sullivan LS, Mintz-Hittner HA, Birch D, Heckenlively
JR, Freund CL, McInnes RR, Daiger SP. A range of clinical phenotypes
associated with mutations in CRX, a photoreceptor transcription-factor
gene. Am J Hum Genet 1998; 63:1307-15.
6. Morimura H, Fishman GA, Grover SA, Fulton AB, Berson EL, Dryja TP.
Mutations in the RPE65 gene in patients with autosomal recessive
retinitis pigmentosa or Leber congenital amaurosis. Proc Natl Acad Sci U
S A 1998; 95:3088-93.
7. den Hollander AI, ten Brink JB, de Kok YJ, van Soest S, van den
Born LI, van Driel MA, van de Pol DJ, Payne AM, Bhattacharya SS, Kellner
U, Hoyng CB, Westerveld A, Brunner HG, Bleeker-Wagemakers EM, Deutman
AF, Heckenlively JR, Cremers FP, Bergen AA. Mutations in a human
homologue of Drosophila crumbs cause retinitis pigmentosa (RP12). Nat
Genet 1999; 23:217-21.
8. Lotery AJ, Jacobson SG, Fishman GA, Weleber RG, Fulton AB,
Namperumalsamy P, Heon E, Levin AV, Grover S, Rosenow JR, Kopp KK,
Sheffield VC, Stone EM. Mutations in the CRB1 gene cause Leber
congenital amaurosis. Arch Ophthalmol 2001; 119:415-20.
9. den Hollander AI, Heckenlively JR, van den Born LI, de Kok YJ, van
der Velde-Visser SD, Kellner U, Jurklies B, van Schooneveld MJ,
Blankenagel A, Rohrschneider K, Wissinger B, Cruysberg JR, Deutman AF,
Brunner HG, Apfelstedt-Sylla E, Hoyng CB, Cremers FP. Leber congenital
amaurosis and retinitis pigmentosa with Coats-like exudative
vasculopathy are associated with mutations in the crumbs homologue 1
(CRB1) gene. Am J Hum Genet 2001; 69:198-203.
10. Eudy JD, Weston MD, Yao S, Hoover DM, Rehm HL, Ma-Edmonds M, Yan
D, Ahmad I, Cheng JJ, Ayuso C, Cremers C, Davenport S, Moller C,
Talmadge CB, Beisel KW, Tamayo M, Morton CC, Swaroop A, Kimberling WJ,
Sumegi J. Mutation of a gene encoding a protein with extracellular
matrix motifs in Usher syndrome type IIa. Science 1998; 280:1753-7.
11. Rivolta C, Sweklo EA, Berson EL, Dryja TP. Missense mutation in
the USH2A gene: association with recessive retinitis pigmentosa without
hearing loss. Am J Hum Genet 2000; 66:1975-8.
12. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML,
Allikmets R, Zack DJ, Kakuk LE, Lagali PS, Wong PW, MacDonald IM,
Sieving PA, Figueroa DJ, Austin CP, Gould RJ, Ayyagari R, Petrukhin K. A
5-bp deletion in ELOVL4 is associated with two related forms of
autosomal dominant macular dystrophy. Nat Genet 2001; 27:89-93.
13. Edwards AO, Donoso LA, Ritter R 3rd. A novel gene for autosomal
dominant Stargardt-like macular dystrophy with homology to the SUR4
protein family. Invest Ophthalmol Vis Sci 2001; 42:2652-63.
14. Bernstein PS, Tammur J, Singh N, Hutchinson A, Dixon M, Pappas
CM, Zabriskie NA, Zhang K, Petrukhin K, Leppert M, Allikmets R. Diverse
macular dystrophy phenotype caused by a novel complex mutation in the
ELOVL4 gene. Invest Ophthalmol Vis Sci 2001; 42:3331-6.
15. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and
nonsense-mediated decay. Cell 1999; 96:307-10.
16. Ayyagari R, Zhang K, Hutchinson A, Yu Z, Swaroop A, Kakuk LE,
Seddon JM, Bernstein PS, Lewis RA, Tammur J, Yang Z, Li Y, Zhang H,
Yashar BM, Liu J, Petrukhin K, Sieving PA, Allikmets R. Evaluation of
the ELOVL4 gene in patients with age-related macular degeneration.
Ophthalmic Genet 2001; 22:233-9.
17. Ruiz A, Borrego S, Marcos I, Antinolo G. A major locus for
autosomal recessive retinitis pigmentosa on 6q, determined by
homozygosity mapping of chromosomal regions that contain
gamma-aminobutyric acid-receptor clusters. Am J Hum Genet 1998;
62:1452-9.
18. Khaliq S, Hameed A, Ismail M, Mehdi SQ, Bessant DA, Payne AM,
Bhattacharya SS. Refinement of the locus for autosomal recessive
Retinitis pigmentosa (RP25) linked to chromosome 6q in a family of
Pakistani origin. Am J Hum Genet 1999; 65:571-4.
19. Dharmaraj S, Li Y, Robitaille JM, Silva E, Zhu D, Mitchell TN,
Maltby LP, Baffoe-Bonnie AB, Maumenee IH. A novel locus for Leber
congenital amaurosis maps to chromosome 6q. Am J Hum Genet 2000;
66:319-26.
20. Li Y, Marcos I, Borrego S, Yu Z, Zhang K, Antinolo G. Evaluation
of the ELOVL4 gene in families with retinitis pigmentosa linked to the
RP25 locus. J Med Genet 2001; 38:478-80.